Total Payments
$25,742
2024 Payments
$8,029
Companies
15
Transactions
89
Medicare Patients
850
Medicare Billing
$149,427
Payment Breakdown by Category
Consulting$22,047 (85.6%)
Food & Beverage$2,459 (9.6%)
Travel$859.10 (3.3%)
Other$370.78 (1.4%)
Education$6.81 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $22,047 | 7 | 85.6% |
| Food and Beverage | $2,459 | 76 | 9.6% |
| Travel and Lodging | $859.10 | 4 | 3.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $370.78 | 1 | 1.4% |
| Education | $6.81 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $8,066 | 13 | $0 (2024) |
| Clovis Oncology, Inc. | $7,359 | 14 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $4,945 | 7 | $0 (2018) |
| Eisai Inc. | $2,400 | 1 | $0 (2020) |
| Merck Sharp & Dohme LLC | $1,036 | 7 | $0 (2023) |
| TESARO, Inc. | $923.00 | 23 | $0 (2019) |
| F. Hoffmann-La Roche AG | $370.78 | 1 | $0 (2019) |
| Kyowa Kirin, Inc. | $161.04 | 7 | $0 (2019) |
| Genentech USA, Inc. | $153.38 | 4 | $0 (2018) |
| Amgen Inc. | $137.74 | 6 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $8,029 | 12 | GlaxoSmithKline, LLC. ($8,029) |
| 2023 | $915.00 | 2 | Merck Sharp & Dohme LLC ($915.00) |
| 2022 | $37.23 | 1 | GlaxoSmithKline, LLC. ($37.23) |
| 2021 | $23.05 | 1 | Myriad Genetic Laboratories, Inc. ($23.05) |
| 2020 | $2,400 | 1 | Eisai Inc. ($2,400) |
| 2019 | $7,666 | 9 | Clovis Oncology, Inc. ($7,200) |
| 2018 | $1,070 | 35 | TESARO, Inc. ($633.80) |
| 2017 | $5,602 | 28 | AstraZeneca Pharmaceuticals LP ($4,890) |
All Payment Transactions
89 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/18/2024 | GlaxoSmithKline, LLC. | ZEJULA (Drug), JEMPERLI | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: ONCOLOGY | ||||||
| 03/06/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Consulting Fee | Cash or cash equivalent | $6,800.00 | General |
| Category: ONCOLOGY | ||||||
| 02/26/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Travel and Lodging | Cash or cash equivalent | $170.83 | General |
| Category: ONCOLOGY | ||||||
| 02/26/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Food and Beverage | Cash or cash equivalent | $14.15 | General |
| Category: ONCOLOGY | ||||||
| 02/07/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $94.25 | General |
| 02/07/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $91.48 | General |
| 02/07/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $76.23 | General |
| 02/07/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $34.65 | General |
| 02/07/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $34.65 | General |
| 02/06/2024 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $300.31 | General |
| 01/29/2024 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $357.32 | General |
| 01/29/2024 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $30.64 | General |
| 05/17/2023 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $610.00 | General |
| 03/06/2023 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $305.00 | General |
| 09/29/2022 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $37.23 | General |
| 09/30/2021 | Myriad Genetic Laboratories, Inc. | myChoice CDx (Device) | Food and Beverage | Cash or cash equivalent | $23.05 | General |
| Category: Tumor DNA Genetic Oncology Analysis | ||||||
| 06/23/2020 | Eisai Inc. | — | Consulting Fee | Cash or cash equivalent | $2,400.00 | General |
| 12/31/2019 | F. Hoffmann-La Roche AG | TECENTRIQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $370.78 | General |
| Category: BioOncology | ||||||
| 04/16/2019 | Clovis Oncology, Inc. | Rubraca (Drug) | Consulting Fee | Cash or cash equivalent | $5,099.11 | General |
| Category: Oncology | ||||||
| 04/03/2019 | Kyowa Kirin, Inc. | SANCUSO (Drug) | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: ANTIEMETIC - 5HT3 INHIBITOR | ||||||
| 03/26/2019 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $15.20 | General |
| 03/15/2019 | Clovis Oncology, Inc. | Rubraca (Drug) | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: Oncology | ||||||
| 03/15/2019 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $84.56 | General |
| Category: Oncology | ||||||
| 03/15/2019 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Oncology | ||||||
| 03/06/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 193 | 323 | $188,275 | $32,792 |
| 2022 | 4 | 206 | 391 | $234,985 | $41,853 |
| 2021 | 4 | 227 | 419 | $243,090 | $46,804 |
| 2020 | 5 | 224 | 320 | $165,005 | $27,979 |
Total Patients
850
Total Services
1,453
Medicare Billing
$149,427
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 88 | 207 | $134,550 | $22,431 | 16.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 69 | 80 | $30,400 | $5,695 | 18.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $14,700 | $3,093 | 21.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $8,625 | $1,574 | 18.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 110 | 281 | $182,650 | $31,361 | 17.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 58 | 72 | $27,360 | $5,220 | 19.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 25 | 25 | $17,500 | $3,901 | 22.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 13 | 13 | $7,475 | $1,371 | 18.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 108 | 282 | $180,060 | $32,761 | 18.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 83 | 101 | $35,790 | $7,641 | 21.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 24 | 24 | $16,800 | $3,858 | 23.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 12 | 12 | $10,440 | $2,545 | 24.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 91 | 157 | $102,050 | $14,536 | 14.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 92 | 120 | $37,200 | $7,749 | 20.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 18 | 18 | $12,600 | $2,643 | 21.0% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 12 | 12 | $10,440 | $2,199 | 21.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 11 | 13 | $2,715 | $852.39 | 31.4% |
About Dr. Jason Wright, M.D
Dr. Jason Wright, M.D is a Gynecologic Oncology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1811941792.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jason Wright, M.D has received a total of $25,742 in payments from pharmaceutical and medical device companies, with $8,029 received in 2024. These payments were reported across 89 transactions from 15 companies. The most common payment nature is "Consulting Fee" ($22,047).
As a Medicare-enrolled provider, Wright has provided services to 850 Medicare beneficiaries, totaling 1,453 services with total Medicare billing of $149,427. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Gynecologic Oncology
- Location New York, NY
- Active Since 05/22/2006
- Last Updated 03/29/2023
- Taxonomy Code 207VX0201X
- Entity Type Individual
- NPI Number 1811941792
Products in Payments
- Rubraca (Drug) $7,358
- JEMPERLI (Biological) $6,985
- LYNPARZA (Drug) $4,853
- ZEJULA (Drug) $791.59
- TECENTRIQ (Biological) $370.78
- Avastin (Biological) $153.38
- SANCUSO (Drug) $136.92
- Neulasta (Biological) $122.54
- TruClear (Device) $114.60
- FASLODEX (Drug) $70.40
- LYNPARZA (Biological) $44.54
- VARUBI (Drug) $40.92
- FARESTON (Drug) $24.12
- ENSEAL Product Family (Device) $23.82
- myChoice CDx (Device) $23.05
- BRILINTA (Drug) $21.85
- MD cobas Instruments and Reagents (Device) $15.69
- KEYTRUDA (Biological) $13.36
- Orilissa (Drug) $13.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gynecologic Oncology Doctors in New York
Bhavana Pothuri, M.d, M.D
Gynecologic Oncology — Payments: $299,385
Gynecologic Oncology $299,385
Mario Leitao, M.d, M.D
Gynecologic Oncology — Payments: $132,719
Gynecologic Oncology $132,719
Dr. Konstantin Zakashansky, M.d, M.D
Gynecologic Oncology — Payments: $113,159
Gynecologic Oncology $113,159
Evelyn Cantillo, M.d, M.D
Gynecologic Oncology — Payments: $78,767
Gynecologic Oncology $78,767
Dr. Jeff Lin, M.d, M.D
Gynecologic Oncology — Payments: $36,366
Gynecologic Oncology $36,366
Dr. Nimesh Nagarsheth, M.d, M.D
Gynecologic Oncology — Payments: $35,225
Gynecologic Oncology $35,225